WITH Boston Special Event
Wednesday, November 14, 2018
6:30PM – 9:30PM
Liberty Hotel, 215 Charles St, Boston, MA 02114
AI Roundtable: Promise and Pitfalls in Healthcare
When it comes to healthcare, is AI living up to the hype? What does the future hold?
Join us for a compelling conversation with Amy Abernethy of Flatiron Healthcare and Anthony Philippakis of the Broad Institute as we explore the answers to these questions and more.
We’re excited to bring this special WITH Boston event to you from the historic Liberty Hotel.
Refresh, learn and connect with WITH colleagues and friends, new and old.
Meet our roundtable panel:
Amy Abernethy M.D., Ph.D.
Chief Medical Officer, Chief Scientific Officer and Senior Vice President, Oncology, Flatiron Health.
Amy is the Chief Medical Officer, Chief Scientific Officer and Senior Vice President, Oncology, where she leads the research oncology, clinical operations and data science teams, and contributes to the strategic vision of Flatiron Health. Before joining Flatiron, Amy was professor of medicine at Duke University School of Medicine, and ran the Center for Learning Health Care in the Duke Clinical Research Institute and Duke Cancer Care Research Program in the Duke Cancer Institute. For more than a decade, she has pioneered the development of technology platforms to spur novel advancements in cancer care, including the development of systems by which aggregated clinical data can support personalized medicine, outcomes research, cancer care quality monitoring, and scientific discovery.
With over 400 peer-reviewed publications, Amy is an internationally recognized expert in clinical trials, cancer outcomes research, health policy, health services research, patient reported outcomes, clinical informatics and patient-centered care. She maintains a close affiliation with Duke, and is a member of the National Academy of Medicine’s National Cancer Policy Forum, past president of the American Academy of Hospice & Palliative Medicine, recent member of the Board of Directors for the Personalized Medicine Coalition, and recent leader within several federally-funded research networks. She also serves on the Board of Directors for athenahealth.
Amy received her MD at Duke University, where she also did her internal medicine residency, served as chief resident and completed her hematology/oncology fellowship. She has her PhD from Flinders University in Australia, focused on evidence-based medicine and clinical informatics, and her Bachelor’s degree from the University of Pennsylvania.
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Institute Scientist
Anthony Philippakis is the Chief Data Officer of the Broad Institute of MIT and Harvard, where he is also an institute scientist.
Philippakis is committed to bridging the gap between data sciences and medicine. He is a cardiologist at Brigham and Women’s Hospital, where his primary focus is caring for patients with rare genetic cardiovascular diseases. At the Broad Institute he directs the Data Sciences Platform, an organization of over 100 software engineers and computational biologists that develops software for analyzing genomic and clinical data. In addition to his roles at the Broad Institute and Brigham and Women’s Hospital, Philippakis is a Venture Partner at GV, focusing on machine learning, distributed computing, and genomics.
Philippakis received his M.D. from Harvard Medical School and completed a Ph.D. in biophysics at Harvard. As an undergraduate, he studied mathematics at Yale University, and later completed the Part III (equivalent to M.Phil) in mathematics at Cambridge University.
